106 related articles for article (PubMed ID: 21864790)
1. Self-organizing map of gene regulatory networks for cell phenotypes during reprogramming.
Zhang L; Zheng Y; Li D; Zhong Y
Comput Biol Chem; 2011 Aug; 35(4):211-7. PubMed ID: 21864790
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide reprogramming in hybrids of somatic cells and embryonic stem cells.
Ambrosi DJ; Tanasijevic B; Kaur A; Obergfell C; O'Neill RJ; Krueger W; Rasmussen TP
Stem Cells; 2007 May; 25(5):1104-13. PubMed ID: 17272499
[TBL] [Abstract][Full Text] [Related]
3. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.
Prigione A; Fauler B; Lurz R; Lehrach H; Adjaye J
Stem Cells; 2010 Apr; 28(4):721-33. PubMed ID: 20201066
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming adult hematopoietic cells.
Kaneko S; Otsu M; Nakauchi H
Curr Opin Hematol; 2010 Jul; 17(4):271-5. PubMed ID: 20571391
[TBL] [Abstract][Full Text] [Related]
5. Modulation of chromatin modifying factors' gene expression in embryonic and induced pluripotent stem cells.
Luzzani C; Solari C; Losino N; Ariel W; Romorini L; Bluguermann C; Sevlever G; Barañao L; Miriuka S; Guberman A
Biochem Biophys Res Commun; 2011 Jul; 410(4):816-22. PubMed ID: 21703227
[TBL] [Abstract][Full Text] [Related]
6. Shared gene regulation during human somatic cell reprogramming.
Wang X; Chen X; Zhang H; Qin W; Xue Y; Zeng F
J Genet Genomics; 2012 Dec; 39(12):613-23. PubMed ID: 23273765
[TBL] [Abstract][Full Text] [Related]
7. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
Hussein SM; Nagy AA
Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
[TBL] [Abstract][Full Text] [Related]
8. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
9. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
Anastasia L; Pelissero G; Venerando B; Tettamanti G
Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
[TBL] [Abstract][Full Text] [Related]
10. Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.
Parameswaran S; Balasubramanian S; Rao MS; Ahmad I
Stem Cells; 2011 Jul; 29(7):1013-20. PubMed ID: 21544901
[TBL] [Abstract][Full Text] [Related]
11. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
[TBL] [Abstract][Full Text] [Related]
12. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion.
Hasegawa K; Zhang P; Wei Z; Pomeroy JE; Lu W; Pera MF
Stem Cells; 2010 Aug; 28(8):1338-48. PubMed ID: 20572011
[TBL] [Abstract][Full Text] [Related]
13. Telomere rejuvenation during nuclear reprogramming.
Marión RM; Blasco MA
Curr Opin Genet Dev; 2010 Apr; 20(2):190-6. PubMed ID: 20176474
[TBL] [Abstract][Full Text] [Related]
14. TaqMan® OpenArray® high-throughput transcriptional analysis of human embryonic and induced pluripotent stem cells.
Patel SN; Wu Y; Bao Y; Mancebo R; Au-Young J; Grigorenko E
Methods Mol Biol; 2013; 997():191-201. PubMed ID: 23546757
[TBL] [Abstract][Full Text] [Related]
15. Nucleosome organizations in induced pluripotent stem cells reprogrammed from somatic cells belonging to three different germ layers.
Tao Y; Zheng W; Jiang Y; Ding G; Hou X; Tang Y; Li Y; Gao S; Chang G; Zhang X; Liu W; Kou X; Wang H; Jiang C; Gao S
BMC Biol; 2014 Dec; 12():109. PubMed ID: 25528259
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomics of protein complexes and their implications for cell reprograming and pluripotency.
Sudhir PR; Kumari MP; Hsu WT; Massiot J; Chen CH; Kuo HC; Chen CH
J Proteome Res; 2013 Dec; 12(12):5878-90. PubMed ID: 24256468
[TBL] [Abstract][Full Text] [Related]
17. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
[TBL] [Abstract][Full Text] [Related]
18. Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.
Nagai K; Ishii H; Miyoshi N; Hoshino H; Saito T; Sato T; Tomimaru Y; Kobayashi S; Nagano H; Sekimoto M; Doki Y; Mori M
Biochem Biophys Res Commun; 2010 Apr; 395(2):258-63. PubMed ID: 20381452
[TBL] [Abstract][Full Text] [Related]
19. Defining pluripotent stem cells through quantitative proteomic analysis.
Reiland S; Salekdeh GH; Krijgsveld J
Expert Rev Proteomics; 2011 Feb; 8(1):29-42. PubMed ID: 21329426
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
Kang L; Kou Z; Zhang Y; Gao S
J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]